Sailer Michael
MS Ambulanz & Restaurative Neurologie, Neurologische Universitätsklinik, Otto-von-Guericke Universität Magdeburg.
Anasthesiol Intensivmed Notfallmed Schmerzther. 2010 May;45(5):328-34. doi: 10.1055/s-0030-1253567. Epub 2010 May 7.
Multiple sclerosis (MS) is an inflammatory disease the central nervous system. Its first manifestation and clinical course of the disease is highly heterogeneous. The diagnosis is based on the verification of neurological deficits, the development of the clinical course and the magnetic resonance imaging (MRI) of the head and spine. The therapy comprises disease modifying drugs (DMD), therapy for acute relapses and escalation therapy according the German MS-Therapy-Consensus-Group (MSTKG). An early therapy initiation and a systematic therapy of acute relapses and symptoms determine the modern MS-management.
多发性硬化症(MS)是一种中枢神经系统的炎症性疾病。其首发症状和疾病临床过程具有高度异质性。诊断基于神经功能缺损的核实、临床病程的发展以及头部和脊柱的磁共振成像(MRI)。治疗包括疾病修正药物(DMD)、急性复发的治疗以及根据德国多发性硬化症治疗共识小组(MSTKG)的升级治疗。早期开始治疗以及对急性复发和症状进行系统治疗决定了现代多发性硬化症的管理。